104 related articles for article (PubMed ID: 25807104)
1. Testosterone membrane-initiated action in breast cancer cells: Interaction with the androgen signaling pathway and EPOR.
Pelekanou V; Notas G; Sanidas E; Tsapis A; Castanas E; Kampa M
Mol Oncol; 2010 Apr; 4(2):135-49. PubMed ID: 20189893
[TBL] [Abstract][Full Text] [Related]
2. Emerging EPO and EPO receptor regulators and signal transducers.
Kuhrt D; Wojchowski DM
Blood; 2015 Jun; 125(23):3536-41. PubMed ID: 25887776
[TBL] [Abstract][Full Text] [Related]
3. Agonists of the tissue-protective erythropoietin receptor in the treatment of Parkinson's disease.
Punnonen J; Miller JL; Collier TJ; Spencer JR
Curr Top Med Chem; 2015; 15(10):955-69. PubMed ID: 25832721
[TBL] [Abstract][Full Text] [Related]
4. Discovery and Characterization of Nonpeptidyl Agonists of the Tissue-Protective Erythropoietin Receptor.
Miller JL; Church TJ; Leonoudakis D; Lariosa-Willingham K; Frigon NL; Tettenborn CS; Spencer JR; Punnonen J
Mol Pharmacol; 2015 Aug; 88(2):357-67. PubMed ID: 26018904
[TBL] [Abstract][Full Text] [Related]
5. Subvisible (2-100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and Strategy.
Narhi LO; Corvari V; Ripple DC; Afonina N; Cecchini I; Defelippis MR; Garidel P; Herre A; Koulov AV; Lubiniecki T; Mahler HC; Mangiagalli P; Nesta D; Perez-Ramirez B; Polozova A; Rossi M; Schmidt R; Simler R; Singh S; Spitznagel TM; Weiskopf A; Wuchner K
J Pharm Sci; 2015 Jun; 104(6):1899-1908. PubMed ID: 25832583
[TBL] [Abstract][Full Text] [Related]
6. The role of erythrocytes and erythroid progenitor cells in tumors.
Zhang H; Wan GZ; Wang YY; Chen W; Guan JZ
Open Life Sci; 2022; 17(1):1641-1656. PubMed ID: 36567722
[TBL] [Abstract][Full Text] [Related]
7. Pan-Cancer Analysis Based on
Zhang Y; Wang S; Han S; Feng Y
Front Oncol; 2022; 12():844794. PubMed ID: 35359375
[TBL] [Abstract][Full Text] [Related]
8. An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma.
Xu Q; Chen Y
Front Cell Dev Biol; 2021; 9():685379. PubMed ID: 34277626
[TBL] [Abstract][Full Text] [Related]
9. Multiorgan Signaling Mobilizes Tumor-Associated Erythroid Cells Expressing Immune Checkpoint Molecules.
Sano Y; Yoshida T; Choo MK; Jiménez-Andrade Y; Hill KR; Georgopoulos K; Park JM
Mol Cancer Res; 2021 Mar; 19(3):507-515. PubMed ID: 33234577
[TBL] [Abstract][Full Text] [Related]
10. Effect of fetal bovine serum on erythropoietin receptor expression and viability of breast cancer cells.
Teo GY; Rasedee A; Al-Haj NA; Beh CY; How CW; Rahman HS; Alitheen NB; Rosli R; Abdullah AH; Ali AS
Saudi J Biol Sci; 2020 Feb; 27(2):653-658. PubMed ID: 32210684
[TBL] [Abstract][Full Text] [Related]
11. Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling.
Held MA; Greenfest-Allen E; Su S; Stoeckert CJ; Stokes MP; Wojchowski DM
Cell Signal; 2020 May; 69():109554. PubMed ID: 32027948
[TBL] [Abstract][Full Text] [Related]
12. Methylation of the first exon in the erythropoietin receptor gene does not correlate with its mRNA and protein level in cancer cells.
Fecková B; Kimáková P; Ilkovičová L; Szentpéteriová E; Macejová M; Košuth J; Zulli A; Debeljak N; Hudler P; Jašek K; Kašubová I; Kubatka P; Solár P
BMC Genet; 2019 Jan; 20(1):1. PubMed ID: 30606107
[TBL] [Abstract][Full Text] [Related]
13. Effects of erythropoietin receptor activity on angiogenesis, tubular injury, and fibrosis in acute kidney injury: a "U-shaped" relationship.
Shi M; Flores B; Li P; Gillings N; McMillan KL; Ye J; Huang LJ; Sidhu SS; Zhong YP; Grompe MT; Streeter PR; Moe OW; Hu MC
Am J Physiol Renal Physiol; 2018 Apr; 314(4):F501-F516. PubMed ID: 29187371
[TBL] [Abstract][Full Text] [Related]
14. Local blockage of self-sustainable erythropoietin signaling suppresses tumor progression in non-small cell lung cancer.
He L; Wu S; Hao Q; Dioum EM; Zhang K; Zhang C; Li W; Zhang W; Zhang Y; Zhou J; Pang Z; Zhao L; Ma X; Li M; Zhang Q
Oncotarget; 2017 Oct; 8(47):82352-82365. PubMed ID: 29137269
[TBL] [Abstract][Full Text] [Related]
15. Incorporating gold nanoclusters and target-directed liposomes as a synergistic amplified colorimetric sensor for HER2-positive breast cancer cell detection.
Tao Y; Li M; Kim B; Auguste DT
Theranostics; 2017; 7(4):899-911. PubMed ID: 28382162
[TBL] [Abstract][Full Text] [Related]
16. MiRNA-323-5p Promotes U373 Cell Apoptosis by Reducing IGF-1R.
Yang HA; Wang X; Ding F; Pang Q
Med Sci Monit; 2015 Dec; 21():3880-6. PubMed ID: 26656446
[TBL] [Abstract][Full Text] [Related]
17. Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.
Rainville N; Jachimowicz E; Wojchowski DM
Expert Opin Ther Targets; 2016; 20(3):287-301. PubMed ID: 26419263
[TBL] [Abstract][Full Text] [Related]
18. Functional EpoR pathway utilization is not detected in primary tumor cells isolated from human breast, non-small cell lung, colorectal, and ovarian tumor tissues.
Patterson SD; Rossi JM; Paweletz KL; Fitzpatrick VD; Begley CG; Busse L; Elliott S; McCaffery I
PLoS One; 2015; 10(3):e0122149. PubMed ID: 25807104
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells.
Accornero P; Miretti S; Starvaggi Cucuzza L; Martignani E; Baratta M
J Mol Endocrinol; 2010 Feb; 44(2):115-25. PubMed ID: 19850646
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
